1-3 of 3
Harriet Goh
Close
Sort by
Journal Articles

Specific Drug Transporter Genotypes Are Significantly Associated with Increased Rates of Major and Complete Molecular Responses In Newly Diagnosed Chronic Myeloid Leukemia Patients Treated with Imatinib – A TOPS Correlative Substudy

Simona Soverini, Sabrina Angelini, Eleonora Turrini, Matt Burnett, Gloria Ravegnini, Mark Thornquist, Fabrizio Pane, MD, Fabrizio Quarantelli, Timothy P. Hughes, Deborah L. White, Dong-Wook Kim, MD, Harriet Goh, Jerald P. Radich, MD, Lan Beppu, Giuseppe Saglio, MD, PhD, Daniela Cilloni, Ilaria Iacobucci, Giovanni Perini, Giorgio Cantelli Forti, Gianantonio Rosti, Alan Hatfield, MD, Michele Baccarani, MD, Patrizia Hrelia, Giovanni Martinelli
Journal: Blood
Blood (2010) 116 (21): 670.
https://doi.org/10.1182/blood.V116.21.670.670
Published: 2010
Journal Articles

Association Between Imatinib (IM) Transporters and Metabolizing Enzymes Genotype and Response in Newly Diagnosed Chronic Myeloid Leukemia (CML) Patients (Pts) Is Influenced by Ethnicity.

Simona Soverini, PhD, Sabrina Angelini, Eleonora Turrini, Fabrizio Pane, MD, Fabrizio Quarantelli, Timothy P. Hughes, MD, MBBS, Deborah L White, PhD, Dong Wook Kim, Harriet Goh, Jerald Radich, Lan Beppu, Giuseppe Saglio, Daniela Cilloni, MD, Carolina Terragna, Sandra Durante, Ilaria Iacobucci, PhD, Giovanni Perini, Ph.D., Patrizia Hrelia, Giorgio Cantelli Forti, Thea Kalebic, MD, Matt Barnett, Mark Thornquist, Michele Baccarani, MD, Giovanni Martinelli
Journal: Blood
Blood (2009) 114 (22): 3283.
https://doi.org/10.1182/blood.V114.22.3283.3283
Published: 2009
Journal Articles

Pleural Effusion in Dasatinib-Treated Chronic Myeloid Leukemia Patients after Imatinib Failure

Dongho Kim, PhD, Il-Young Kweon, Sa-Hee Park, Ji-Sun Lim, Hey-Sun Chung, Ha-Na Kim, Harriet Goh, Soo-Hyun Kim, Jung Lee, Won- Seok Kim, PhD, Dong-Wook Kim, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 4270.
https://doi.org/10.1182/blood.V112.11.4270.4270
Published: 2008